SDHC phaeochromocytoma and paraganglioma: A UK‐wide case series
- 24 September 2021
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 96 (4) , 499-512
Abstract
Objective: Phaeochromocytomas and paragangliomas (PPGL) are rare, but strongly heritable tumours. Variants in succinate dehydrogenase (SDH) subunits are identified in approximately 25% of cases. However, clinical and genetic information of patients with SDHC variants are underreported.Design: This retrospective case series collated data from 18 UK Genetics and Endocrinology departments.Patients: Both asymptomatic and disease‐affected patients with confirmed SDHC germline variants are included.Measurements: Clinical data including tumour type and location, surveillance outcomes and interventions, SDHC genetic variant assessment, interpretation, and tumour risk calculation.Results: We report 91 SDHC cases, 46 probands and 45 non‐probands. Fifty‐one cases were disease‐affected. Median age at genetic diagnosis was 43 years (range: 11–79). Twenty‐four SDHC germline variants were identified including six novel variants. Head and neck paraganglioma (HNPGL, n = 30, 65.2%), extra‐adrenal paraganglioma (EAPGL, n = 13, 28.2%) and phaeochromocytomas (PCC) (n = 3, 6.5%) were present. One case had multiple PPGLs. Malignant disease was reported in 19.6% (9/46). Eight cases had non‐PPGL SDHC‐associated tumours, six gastrointestinal stromal tumours (GIST) and two renal cell cancers (RCC). Cumulative tumour risk (95% CI) at age 60 years was 0.94 (CI: 0.79–0.99) in probands, and 0.16 (CI: 0–0.31) in non‐probands, respectively.Conclusions: This study describes the largest cohort of 91 SDHC patients worldwide. We confirm disease‐affected SDHC variant cases develop isolated HNPGL disease in nearly 2/3 of patients, EAPGL and PCC in 1/3, with an increased risk of GIST and RCC. One fifth developed malignant disease, requiring comprehensive lifelong tumour screening and surveillance.Keywords
This publication has 31 references indexed in Scilit:
- DUET: a server for predicting effects of mutations on protein stability using an integrated computational approachNucleic Acids Research, 2014
- Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneityNature Reviews Cancer, 2014
- MutPred Splice: machine learning-based prediction of exonic variants that disrupt splicingGenome Biology, 2014
- A Decade (2001-2010) of Genetic Testing for Pheochromocytoma and ParagangliomaHormone and Metabolic Research, 2012
- The Succinate Dehydrogenase Genetic Testing in a Large Prospective Series of Patients with ParagangliomasThe Journal of Clinical Endocrinology & Metabolism, 2009
- Succinate Dehydrogenase B Gene Mutations Predict Survival in Patients with Malignant Pheochromocytomas or ParagangliomasThe Journal of Clinical Endocrinology & Metabolism, 2007
- Asymptomatic bilateral adrenal pheochromocytoma in a patient with a germline V804M mutation in the RET proto‐oncogeneClinical Endocrinology, 2007
- High Prevalence of Pituitary Adenomas: A Cross-Sectional Study in the Province of Liège, BelgiumThe Journal of Clinical Endocrinology & Metabolism, 2006
- Predictors and Prevalence of Paraganglioma Syndrome Associated With Mutations of the SDHC GeneJAMA, 2005
- Crystal Structure of Mitochondrial Respiratory Membrane Protein Complex IICell, 2005